Ossiam’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $6.26M | Buy |
+49,573
| New | +$6.53M | 0.08% | 150 |
|
|
2025
Q4 | – | Sell |
-80,163
| Closed | -$8.9M | – | 489 |
|
|
2025
Q3 | $8.9M | Buy |
80,163
+52,600
| +191% | +$5.98M | 0.11% | 132 |
|
|
2025
Q2 | $3.06M | Sell |
27,563
-15,066
| -35% | -$1.6M | 0.03% | 216 |
|
|
2025
Q1 | $4.78M | Buy |
42,629
+10,654
| +33% | +$1.1M | 0.07% | 138 |
|
|
2024
Q4 | $2.95M | Buy |
31,975
+1,006
| +3% | +$90.6K | 0.05% | 195 |
|
|
2024
Q3 | $2.6M | Sell |
30,969
-2,607
| -8% | -$199K | 0.05% | 173 |
|
|
2024
Q2 | $2.3M | Buy |
33,576
+5,229
| +18% | +$349K | 0.04% | 194 |
|
|
2024
Q1 | $2.08M | Sell |
28,347
-10,700
| -27% | -$823K | 0.04% | 239 |
|
|
2023
Q4 | $3.16M | Buy |
39,047
+5,456
| +16% | +$425K | 0.05% | 163 |
|
|
2023
Q3 | $2.52M | Sell |
33,591
-68,222
| -67% | -$5.25M | 0.04% | 178 |
|
|
2023
Q2 | $7.85M | Buy |
101,813
+82,142
| +418% | +$6.55M | 0.14% | 115 |
|
|
2023
Q1 | $1.63M | Buy |
19,671
+1,584
| +9% | +$131K | 0.03% | 220 |
|
|
2022
Q4 | $1.55M | Sell |
18,087
-23,814
| -57% | -$1.89M | 0.04% | 221 |
|
|
2022
Q3 | $2.58M | Sell |
41,901
-63,807
| -60% | -$4.02M | 0.07% | 162 |
|
|
2022
Q2 | $6.53M | Sell |
105,708
-171,170
| -62% | -$10.6M | 0.2% | 84 |
|
|
2022
Q1 | $16.5M | Buy |
276,878
+101,716
| +58% | +$6.5M | 0.43% | 54 |
|
|
2021
Q4 | $12.7M | Sell |
175,162
-17,652
| -9% | -$1.22M | 0.33% | 65 |
|
|
2021
Q3 | $13.5M | Sell |
192,814
-65,728
| -25% | -$4.62M | 0.38% | 54 |
|
|
2021
Q2 | $17.7M | Buy |
258,542
+26,504
| +11% | +$1.77M | 0.48% | 49 |
|
|
2021
Q1 | $15M | Buy |
232,038
+90,343
| +64% | +$5.83M | 0.47% | 51 |
|
|
2020
Q4 | $8.26M | Buy |
141,695
+71,444
| +102% | +$4.31M | 0.29% | 77 |
|
|
2020
Q3 | $4.44M | Buy |
70,251
+977
| +1% | +$67.8K | 0.19% | 89 |
|
|
2020
Q2 | $5.33M | Buy |
69,274
+23,456
| +51% | +$1.8M | 0.34% | 62 |
|
|
2020
Q1 | $3.42M | Buy |
45,818
+44,127
| +2,610% | +$3.05M | 0.23% | 87 |
|
|
2019
Q4 | $110K | Buy |
1,691
+1,386
| +454% | +$90.3K | 0.01% | 383 |
|
|
2019
Q3 | $19K | Sell |
305
-40,835
| -99% | -$2.67M | ﹤0.01% | 458 |
|
|
2019
Q2 | $2.78M | Buy |
+41,140
| New | +$2.71M | 0.22% | 100 |
|
|
2019
Q1 | – | Sell |
-219,960
| Closed | -$13.8M | – | 294 |
|
|
2018
Q4 | $13.8M | Buy |
+219,960
| New | +$15.4M | 2.07% | 10 |
|
Other funds holding GILD
Ossiam's GILD Position: Q2 2026 in Review
Ossiam opened a new position in Gilead Sciences (GILD) in Q2 2026: 49,573 shares worth $6.26M. The stake represents 0.08% of the portfolio and ranks #150 among its holdings. This is a return to the name: Ossiam previously reported a position in GILD as recently as Q3 2025.
Ossiam first reported a position in GILD in Q4 2018 and has held it in 28 quarters since. The position peaked at $17.7M in Q2 2021. 2,278 funds tracked by Wall St. Rank hold GILD as of Q2 2026.
- Ossiam held 49,573 shares of Gilead Sciences worth $6.26M as of Q2 2026.
- Gilead Sciences was a new Ossiam position in Q2 2026.
- Gilead Sciences made up 0.08% of Ossiam's portfolio in Q2 2026, its #150 holding.
- Ossiam first reported a position in Gilead Sciences in Q4 2018 and has held it in 28 quarters since.
- Ossiam's Gilead Sciences position peaked at $17.7M in Q2 2021.
- 2,278 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.
Based on Ossiam's 13F filing for Q2 2026, filed 13 Aug 2026.